481
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Chemotherapy-induced mucositis development in a murine model of colitis-associated colorectal cancer

, &
Pages 47-54 | Received 25 Oct 2019, Accepted 26 Nov 2019, Published online: 11 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Suzanne Mashtoub, Lauren C. Chartier, Debbie Trinder, Ian C. Lawrance & Gordon S. Howarth. (2022) Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mouse Model of Colitis-Associated Colorectal Cancer. Nutrition and Cancer 74:2, pages 715-723.
Read now

Articles from other publishers (5)

Ruizheng Sun, Hao Chen, Siqi Yao, Zheng Yu, Chen Lai & Jing Huang. (2023) Ecological and dynamic analysis of gut microbiota in the early stage of azomethane-dextran sodium sulfate model in mice. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Junhua Huang, Alan Yaw Min Hwang, Yuting Jia, Brian Kim, Melania Iskandar, Ali Ibrahim Mohammed & Nicola Cirillo. (2022) Experimental Chemotherapy-Induced Mucositis: A Scoping Review Guiding the Design of Suitable Preclinical Models. International Journal of Molecular Sciences 23:23, pages 15434.
Crossref
Rita Modesto, João Estarreja, Inês Silva, João Rocha, Rui Pinto & Vanessa Mateus. (2022) Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review. Journal of Clinical Medicine 11:10, pages 2739.
Crossref
Alexander T. Sougiannis, Brandon N. VanderVeen, J. Mark Davis, Daping Fan & E. Angela Murphy. (2021) Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience. American Journal of Physiology-Gastrointestinal and Liver Physiology 320:5, pages G712-G719.
Crossref
Lauren C Chartier, Gordon S Howarth, Debbie Trinder & Suzanne Mashtoub. (2021) Emu oil and grape seed extract reduce tumour burden and disease parameters in murine colitis-associated colorectal cancer. Carcinogenesis 42:2, pages 202-209.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.